nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CYP2B6—Thiotepa—urinary bladder cancer	0.102	0.226	CbGbCtD
Nicotine—SLC22A2—Cisplatin—urinary bladder cancer	0.0544	0.12	CbGbCtD
Nicotine—CYP2A6—Fluorouracil—urinary bladder cancer	0.051	0.113	CbGbCtD
Nicotine—CYP3A4—Thiotepa—urinary bladder cancer	0.0314	0.0695	CbGbCtD
Nicotine—CYP2B6—Cisplatin—urinary bladder cancer	0.0282	0.0624	CbGbCtD
Nicotine—CYP2E1—Etoposide—urinary bladder cancer	0.0281	0.0622	CbGbCtD
Nicotine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0252	0.0556	CbGbCtD
Nicotine—CYP2C8—Etoposide—urinary bladder cancer	0.021	0.0464	CbGbCtD
Nicotine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0195	0.0431	CbGbCtD
Nicotine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0189	0.0418	CbGbCtD
Nicotine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0176	0.0388	CbGbCtD
Nicotine—CYP1A2—Etoposide—urinary bladder cancer	0.0163	0.036	CbGbCtD
Nicotine—CYP2C9—Cisplatin—urinary bladder cancer	0.0149	0.033	CbGbCtD
Nicotine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00914	0.0202	CbGbCtD
Nicotine—CYP3A4—Etoposide—urinary bladder cancer	0.00852	0.0188	CbGbCtD
Nicotine—CHRNA5—prostate gland—urinary bladder cancer	0.00801	0.0632	CbGeAlD
Nicotine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00581	0.0128	CbGbCtD
Nicotine—CHRNA5—vagina—urinary bladder cancer	0.00395	0.0312	CbGeAlD
Nicotine—CYP2C19—urine—urinary bladder cancer	0.00395	0.0312	CbGeAlD
Nicotine—CHRNB2—prostate gland—urinary bladder cancer	0.00349	0.0275	CbGeAlD
Nicotine—CHRNA3—prostate gland—urinary bladder cancer	0.00338	0.0267	CbGeAlD
Nicotine—CYP1A2—urine—urinary bladder cancer	0.00323	0.0255	CbGeAlD
Nicotine—CHRNA2—prostate gland—urinary bladder cancer	0.00314	0.0248	CbGeAlD
Nicotine—CYP2C9—urine—urinary bladder cancer	0.00307	0.0242	CbGeAlD
Nicotine—CYP2E1—urine—urinary bladder cancer	0.00291	0.0229	CbGeAlD
Nicotine—CHAT—female reproductive system—urinary bladder cancer	0.00275	0.0217	CbGeAlD
Nicotine—CHRNA5—lymph node—urinary bladder cancer	0.00256	0.0202	CbGeAlD
Nicotine—CHRNB2—smooth muscle tissue—urinary bladder cancer	0.00247	0.0195	CbGeAlD
Nicotine—CHRNA10—vagina—urinary bladder cancer	0.0024	0.0189	CbGeAlD
Nicotine—CYP3A4—urine—urinary bladder cancer	0.00234	0.0185	CbGeAlD
Nicotine—CHRNB2—urethra—urinary bladder cancer	0.00233	0.0184	CbGeAlD
Nicotine—CYP2D6—urine—urinary bladder cancer	0.0023	0.0182	CbGeAlD
Nicotine—CYP2A6—prostate gland—urinary bladder cancer	0.00221	0.0174	CbGeAlD
Nicotine—SLC22A4—prostate gland—urinary bladder cancer	0.00193	0.0153	CbGeAlD
Nicotine—CYP2A6—seminal vesicle—urinary bladder cancer	0.00187	0.0147	CbGeAlD
Nicotine—SLC22A2—renal system—urinary bladder cancer	0.00178	0.014	CbGeAlD
Nicotine—SLC22A3—prostate gland—urinary bladder cancer	0.00176	0.0139	CbGeAlD
Nicotine—CYP19A1—prostate gland—urinary bladder cancer	0.00173	0.0137	CbGeAlD
Nicotine—CHRNB2—vagina—urinary bladder cancer	0.00172	0.0136	CbGeAlD
Nicotine—SLC22A4—seminal vesicle—urinary bladder cancer	0.00164	0.0129	CbGeAlD
Nicotine—MAOB—prostate gland—urinary bladder cancer	0.00163	0.0129	CbGeAlD
Nicotine—CHRNA10—lymph node—urinary bladder cancer	0.00155	0.0122	CbGeAlD
Nicotine—CHRNA7—renal system—urinary bladder cancer	0.00151	0.0119	CbGeAlD
Nicotine—CHRFAM7A—female reproductive system—urinary bladder cancer	0.00149	0.0118	CbGeAlD
Nicotine—SLC22A3—seminal vesicle—urinary bladder cancer	0.00149	0.0118	CbGeAlD
Nicotine—MAOA—prostate gland—urinary bladder cancer	0.00139	0.011	CbGeAlD
Nicotine—MAOB—seminal vesicle—urinary bladder cancer	0.00138	0.0109	CbGeAlD
Nicotine—SLC22A4—renal system—urinary bladder cancer	0.00132	0.0104	CbGeAlD
Nicotine—SLC22A5—prostate gland—urinary bladder cancer	0.00128	0.0101	CbGeAlD
Nicotine—SLC22A1—renal system—urinary bladder cancer	0.00126	0.00991	CbGeAlD
Nicotine—SLC22A3—smooth muscle tissue—urinary bladder cancer	0.00125	0.00984	CbGeAlD
Nicotine—CHRNA7—female reproductive system—urinary bladder cancer	0.00121	0.00952	CbGeAlD
Nicotine—SLC22A3—renal system—urinary bladder cancer	0.0012	0.00947	CbGeAlD
Nicotine—SLC22A3—urethra—urinary bladder cancer	0.00118	0.0093	CbGeAlD
Nicotine—MAOA—seminal vesicle—urinary bladder cancer	0.00118	0.00928	CbGeAlD
Nicotine—CHRNB2—lymph node—urinary bladder cancer	0.00111	0.00879	CbGeAlD
Nicotine—MAOB—renal system—urinary bladder cancer	0.00111	0.00876	CbGeAlD
Nicotine—MAOB—urethra—urinary bladder cancer	0.00109	0.00861	CbGeAlD
Nicotine—CYP2A6—vagina—urinary bladder cancer	0.00109	0.0086	CbGeAlD
Nicotine—SLC22A5—seminal vesicle—urinary bladder cancer	0.00108	0.00855	CbGeAlD
Nicotine—CHRNA3—lymph node—urinary bladder cancer	0.00108	0.00852	CbGeAlD
Nicotine—SLC22A4—female reproductive system—urinary bladder cancer	0.00106	0.00833	CbGeAlD
Nicotine—CYP2E1—prostate gland—urinary bladder cancer	0.00104	0.00823	CbGeAlD
Nicotine—SLC22A3—female reproductive system—urinary bladder cancer	0.000961	0.00759	CbGeAlD
Nicotine—SLC22A4—vagina—urinary bladder cancer	0.000955	0.00754	CbGeAlD
Nicotine—MAOA—renal system—urinary bladder cancer	0.000947	0.00748	CbGeAlD
Nicotine—CYP19A1—female reproductive system—urinary bladder cancer	0.000945	0.00746	CbGeAlD
Nicotine—MAOA—urethra—urinary bladder cancer	0.00093	0.00735	CbGeAlD
Nicotine—SLC22A1—vagina—urinary bladder cancer	0.000909	0.00718	CbGeAlD
Nicotine—MAOB—female reproductive system—urinary bladder cancer	0.000889	0.00702	CbGeAlD
Nicotine—CYP2E1—seminal vesicle—urinary bladder cancer	0.000882	0.00696	CbGeAlD
Nicotine—SLC22A5—renal system—urinary bladder cancer	0.000872	0.00689	CbGeAlD
Nicotine—SLC22A3—vagina—urinary bladder cancer	0.000869	0.00686	CbGeAlD
Nicotine—SLC22A5—urethra—urinary bladder cancer	0.000857	0.00676	CbGeAlD
Nicotine—CYP2C8—renal system—urinary bladder cancer	0.000844	0.00667	CbGeAlD
Nicotine—CYP1A1—epithelium—urinary bladder cancer	0.00084	0.00663	CbGeAlD
Nicotine—MAOB—vagina—urinary bladder cancer	0.000804	0.00635	CbGeAlD
Nicotine—CYP1A2—renal system—urinary bladder cancer	0.00079	0.00624	CbGeAlD
Nicotine—CYP1A1—renal system—urinary bladder cancer	0.000779	0.00615	CbGeAlD
Nicotine—CYP1A1—urethra—urinary bladder cancer	0.000766	0.00605	CbGeAlD
Nicotine—MAOA—female reproductive system—urinary bladder cancer	0.000759	0.00599	CbGeAlD
Nicotine—CYP2B6—renal system—urinary bladder cancer	0.000757	0.00598	CbGeAlD
Nicotine—CYP2E1—renal system—urinary bladder cancer	0.000711	0.00561	CbGeAlD
Nicotine—CYP2C19—vagina—urinary bladder cancer	0.000701	0.00553	CbGeAlD
Nicotine—SLC22A5—female reproductive system—urinary bladder cancer	0.000699	0.00552	CbGeAlD
Nicotine—CYP2E1—urethra—urinary bladder cancer	0.000698	0.00551	CbGeAlD
Nicotine—MAOA—vagina—urinary bladder cancer	0.000686	0.00542	CbGeAlD
Nicotine—CYP2C8—female reproductive system—urinary bladder cancer	0.000676	0.00534	CbGeAlD
Nicotine—SLC22A5—vagina—urinary bladder cancer	0.000632	0.00499	CbGeAlD
Nicotine—CYP1A1—female reproductive system—urinary bladder cancer	0.000624	0.00493	CbGeAlD
Nicotine—SLC22A4—lymph node—urinary bladder cancer	0.000618	0.00488	CbGeAlD
Nicotine—CYP2C8—vagina—urinary bladder cancer	0.000612	0.00483	CbGeAlD
Nicotine—CYP2B6—female reproductive system—urinary bladder cancer	0.000607	0.00479	CbGeAlD
Nicotine—CYP2C9—female reproductive system—urinary bladder cancer	0.000601	0.00474	CbGeAlD
Nicotine—CYP3A4—renal system—urinary bladder cancer	0.000572	0.00452	CbGeAlD
Nicotine—CYP2E1—female reproductive system—urinary bladder cancer	0.000569	0.00449	CbGeAlD
Nicotine—CYP1A1—vagina—urinary bladder cancer	0.000565	0.00446	CbGeAlD
Nicotine—CYP2D6—renal system—urinary bladder cancer	0.000563	0.00444	CbGeAlD
Nicotine—SLC22A3—lymph node—urinary bladder cancer	0.000562	0.00444	CbGeAlD
Nicotine—CYP19A1—lymph node—urinary bladder cancer	0.000553	0.00436	CbGeAlD
Nicotine—CYP2B6—vagina—urinary bladder cancer	0.000549	0.00433	CbGeAlD
Nicotine—MAOB—lymph node—urinary bladder cancer	0.00052	0.00411	CbGeAlD
Nicotine—CYP3A4—female reproductive system—urinary bladder cancer	0.000458	0.00362	CbGeAlD
Nicotine—CYP2D6—female reproductive system—urinary bladder cancer	0.000451	0.00356	CbGeAlD
Nicotine—MAOA—lymph node—urinary bladder cancer	0.000444	0.0035	CbGeAlD
Nicotine—SLC22A5—lymph node—urinary bladder cancer	0.000409	0.00323	CbGeAlD
Nicotine—CYP1A1—lymph node—urinary bladder cancer	0.000365	0.00288	CbGeAlD
Nicotine—Dizziness—Thiotepa—urinary bladder cancer	0.000235	0.000988	CcSEcCtD
Nicotine—Stomatitis—Methotrexate—urinary bladder cancer	0.000234	0.000982	CcSEcCtD
Nicotine—Urticaria—Fluorouracil—urinary bladder cancer	0.000233	0.000981	CcSEcCtD
Nicotine—Influenza—Doxorubicin—urinary bladder cancer	0.000233	0.000979	CcSEcCtD
Nicotine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000233	0.000979	CcSEcCtD
Nicotine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000232	0.000977	CcSEcCtD
Nicotine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00023	0.000965	CcSEcCtD
Nicotine—Paraesthesia—Etoposide—urinary bladder cancer	0.000229	0.000963	CcSEcCtD
Nicotine—Weight increased—Epirubicin—urinary bladder cancer	0.000229	0.000962	CcSEcCtD
Nicotine—Dyspnoea—Etoposide—urinary bladder cancer	0.000228	0.000956	CcSEcCtD
Nicotine—Somnolence—Etoposide—urinary bladder cancer	0.000227	0.000954	CcSEcCtD
Nicotine—Epistaxis—Methotrexate—urinary bladder cancer	0.000226	0.00095	CcSEcCtD
Nicotine—Vomiting—Thiotepa—urinary bladder cancer	0.000226	0.00095	CcSEcCtD
Nicotine—Rash—Thiotepa—urinary bladder cancer	0.000224	0.000942	CcSEcCtD
Nicotine—Bronchitis—Doxorubicin—urinary bladder cancer	0.000224	0.000941	CcSEcCtD
Nicotine—Dermatitis—Thiotepa—urinary bladder cancer	0.000224	0.000941	CcSEcCtD
Nicotine—Headache—Thiotepa—urinary bladder cancer	0.000223	0.000936	CcSEcCtD
Nicotine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00022	0.000926	CcSEcCtD
Nicotine—Body temperature increased—Cisplatin—urinary bladder cancer	0.00022	0.000926	CcSEcCtD
Nicotine—Fatigue—Etoposide—urinary bladder cancer	0.00022	0.000925	CcSEcCtD
Nicotine—Stomatitis—Epirubicin—urinary bladder cancer	0.000219	0.000919	CcSEcCtD
Nicotine—Constipation—Etoposide—urinary bladder cancer	0.000218	0.000917	CcSEcCtD
Nicotine—Pain—Etoposide—urinary bladder cancer	0.000218	0.000917	CcSEcCtD
Nicotine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000217	0.00091	CcSEcCtD
Nicotine—Asthenia—Gemcitabine—urinary bladder cancer	0.000214	0.000901	CcSEcCtD
Nicotine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000214	0.000898	CcSEcCtD
Nicotine—Weight increased—Doxorubicin—urinary bladder cancer	0.000212	0.000891	CcSEcCtD
Nicotine—Epistaxis—Epirubicin—urinary bladder cancer	0.000212	0.000889	CcSEcCtD
Nicotine—Pruritus—Gemcitabine—urinary bladder cancer	0.000211	0.000889	CcSEcCtD
Nicotine—Nausea—Thiotepa—urinary bladder cancer	0.000211	0.000887	CcSEcCtD
Nicotine—Sinusitis—Epirubicin—urinary bladder cancer	0.00021	0.000885	CcSEcCtD
Nicotine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00021	0.000884	CcSEcCtD
Nicotine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000209	0.000877	CcSEcCtD
Nicotine—Pruritus—Fluorouracil—urinary bladder cancer	0.000208	0.000874	CcSEcCtD
Nicotine—Visual impairment—Methotrexate—urinary bladder cancer	0.000207	0.000872	CcSEcCtD
Nicotine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000205	0.000863	CcSEcCtD
Nicotine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000205	0.00086	CcSEcCtD
Nicotine—Urticaria—Etoposide—urinary bladder cancer	0.000203	0.000852	CcSEcCtD
Nicotine—Stomatitis—Doxorubicin—urinary bladder cancer	0.000202	0.00085	CcSEcCtD
Nicotine—Rhinitis—Epirubicin—urinary bladder cancer	0.000202	0.000849	CcSEcCtD
Nicotine—Abdominal pain—Etoposide—urinary bladder cancer	0.000202	0.000848	CcSEcCtD
Nicotine—Body temperature increased—Etoposide—urinary bladder cancer	0.000202	0.000848	CcSEcCtD
Nicotine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000201	0.000845	CcSEcCtD
Nicotine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.0002	0.000842	CcSEcCtD
Nicotine—Asthenia—Cisplatin—urinary bladder cancer	0.0002	0.00084	CcSEcCtD
Nicotine—Pharyngitis—Epirubicin—urinary bladder cancer	0.0002	0.00084	CcSEcCtD
Nicotine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.0002	0.000839	CcSEcCtD
Nicotine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000198	0.000834	CcSEcCtD
Nicotine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000196	0.000823	CcSEcCtD
Nicotine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000195	0.000819	CcSEcCtD
Nicotine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000194	0.000817	CcSEcCtD
Nicotine—Dizziness—Fluorouracil—urinary bladder cancer	0.000194	0.000817	CcSEcCtD
Nicotine—Visual impairment—Epirubicin—urinary bladder cancer	0.000194	0.000816	CcSEcCtD
Nicotine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000194	0.000815	CcSEcCtD
Nicotine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000191	0.000801	CcSEcCtD
Nicotine—Vomiting—Gemcitabine—urinary bladder cancer	0.00019	0.000799	CcSEcCtD
Nicotine—Mental disorder—Methotrexate—urinary bladder cancer	0.000189	0.000792	CcSEcCtD
Nicotine—Rash—Gemcitabine—urinary bladder cancer	0.000188	0.000792	CcSEcCtD
Nicotine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000188	0.000791	CcSEcCtD
Nicotine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000188	0.00079	CcSEcCtD
Nicotine—Erythema—Methotrexate—urinary bladder cancer	0.000187	0.000787	CcSEcCtD
Nicotine—Headache—Gemcitabine—urinary bladder cancer	0.000187	0.000787	CcSEcCtD
Nicotine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000187	0.000786	CcSEcCtD
Nicotine—Flushing—Epirubicin—urinary bladder cancer	0.000187	0.000786	CcSEcCtD
Nicotine—Vomiting—Fluorouracil—urinary bladder cancer	0.000187	0.000785	CcSEcCtD
Nicotine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000187	0.000785	CcSEcCtD
Nicotine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000185	0.000779	CcSEcCtD
Nicotine—Rash—Fluorouracil—urinary bladder cancer	0.000185	0.000779	CcSEcCtD
Nicotine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000185	0.000778	CcSEcCtD
Nicotine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000185	0.000777	CcSEcCtD
Nicotine—Headache—Fluorouracil—urinary bladder cancer	0.000184	0.000774	CcSEcCtD
Nicotine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000184	0.000772	CcSEcCtD
Nicotine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000183	0.000771	CcSEcCtD
Nicotine—Asthenia—Etoposide—urinary bladder cancer	0.000183	0.00077	CcSEcCtD
Nicotine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000182	0.000765	CcSEcCtD
Nicotine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000182	0.000763	CcSEcCtD
Nicotine—Back pain—Methotrexate—urinary bladder cancer	0.000181	0.000762	CcSEcCtD
Nicotine—Pruritus—Etoposide—urinary bladder cancer	0.000181	0.000759	CcSEcCtD
Nicotine—Arrhythmia—Epirubicin—urinary bladder cancer	0.00018	0.000756	CcSEcCtD
Nicotine—Visual impairment—Doxorubicin—urinary bladder cancer	0.00018	0.000755	CcSEcCtD
Nicotine—Nausea—Gemcitabine—urinary bladder cancer	0.000178	0.000746	CcSEcCtD
Nicotine—Vomiting—Cisplatin—urinary bladder cancer	0.000177	0.000745	CcSEcCtD
Nicotine—Mental disorder—Epirubicin—urinary bladder cancer	0.000176	0.000742	CcSEcCtD
Nicotine—Rash—Cisplatin—urinary bladder cancer	0.000176	0.000738	CcSEcCtD
Nicotine—Dermatitis—Cisplatin—urinary bladder cancer	0.000176	0.000738	CcSEcCtD
Nicotine—Erythema—Epirubicin—urinary bladder cancer	0.000175	0.000737	CcSEcCtD
Nicotine—Diarrhoea—Etoposide—urinary bladder cancer	0.000175	0.000734	CcSEcCtD
Nicotine—Nausea—Fluorouracil—urinary bladder cancer	0.000175	0.000734	CcSEcCtD
Nicotine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000174	0.000731	CcSEcCtD
Nicotine—Flushing—Doxorubicin—urinary bladder cancer	0.000173	0.000727	CcSEcCtD
Nicotine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000173	0.000727	CcSEcCtD
Nicotine—Flatulence—Epirubicin—urinary bladder cancer	0.000173	0.000726	CcSEcCtD
Nicotine—Tension—Epirubicin—urinary bladder cancer	0.000172	0.000723	CcSEcCtD
Nicotine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000172	0.000722	CcSEcCtD
Nicotine—Nervousness—Epirubicin—urinary bladder cancer	0.00017	0.000716	CcSEcCtD
Nicotine—Back pain—Epirubicin—urinary bladder cancer	0.00017	0.000713	CcSEcCtD
Nicotine—Malaise—Methotrexate—urinary bladder cancer	0.000169	0.00071	CcSEcCtD
Nicotine—Dizziness—Etoposide—urinary bladder cancer	0.000169	0.000709	CcSEcCtD
Nicotine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000169	0.000708	CcSEcCtD
Nicotine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000168	0.000707	CcSEcCtD
Nicotine—Vertigo—Methotrexate—urinary bladder cancer	0.000168	0.000707	CcSEcCtD
Nicotine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000168	0.000706	CcSEcCtD
Nicotine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000166	0.0007	CcSEcCtD
Nicotine—Nausea—Cisplatin—urinary bladder cancer	0.000165	0.000696	CcSEcCtD
Nicotine—Cough—Methotrexate—urinary bladder cancer	0.000163	0.000687	CcSEcCtD
Nicotine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000163	0.000686	CcSEcCtD
Nicotine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000163	0.000684	CcSEcCtD
Nicotine—Convulsion—Methotrexate—urinary bladder cancer	0.000162	0.000682	CcSEcCtD
Nicotine—Vomiting—Etoposide—urinary bladder cancer	0.000162	0.000682	CcSEcCtD
Nicotine—Erythema—Doxorubicin—urinary bladder cancer	0.000162	0.000682	CcSEcCtD
Nicotine—Agitation—Epirubicin—urinary bladder cancer	0.000161	0.000677	CcSEcCtD
Nicotine—Rash—Etoposide—urinary bladder cancer	0.000161	0.000676	CcSEcCtD
Nicotine—Dermatitis—Etoposide—urinary bladder cancer	0.000161	0.000676	CcSEcCtD
Nicotine—Headache—Etoposide—urinary bladder cancer	0.00016	0.000672	CcSEcCtD
Nicotine—Flatulence—Doxorubicin—urinary bladder cancer	0.00016	0.000672	CcSEcCtD
Nicotine—Chest pain—Methotrexate—urinary bladder cancer	0.000159	0.00067	CcSEcCtD
Nicotine—Myalgia—Methotrexate—urinary bladder cancer	0.000159	0.00067	CcSEcCtD
Nicotine—Arthralgia—Methotrexate—urinary bladder cancer	0.000159	0.00067	CcSEcCtD
Nicotine—Tension—Doxorubicin—urinary bladder cancer	0.000159	0.000669	CcSEcCtD
Nicotine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000159	0.000668	CcSEcCtD
Nicotine—Malaise—Epirubicin—urinary bladder cancer	0.000158	0.000665	CcSEcCtD
Nicotine—Discomfort—Methotrexate—urinary bladder cancer	0.000158	0.000662	CcSEcCtD
Nicotine—Nervousness—Doxorubicin—urinary bladder cancer	0.000158	0.000662	CcSEcCtD
Nicotine—Vertigo—Epirubicin—urinary bladder cancer	0.000158	0.000662	CcSEcCtD
Nicotine—Syncope—Epirubicin—urinary bladder cancer	0.000157	0.000661	CcSEcCtD
Nicotine—Back pain—Doxorubicin—urinary bladder cancer	0.000157	0.00066	CcSEcCtD
Nicotine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000156	0.000656	CcSEcCtD
Nicotine—Palpitations—Epirubicin—urinary bladder cancer	0.000155	0.000651	CcSEcCtD
Nicotine—Confusional state—Methotrexate—urinary bladder cancer	0.000154	0.000648	CcSEcCtD
Nicotine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000154	0.000648	CcSEcCtD
Nicotine—Cough—Epirubicin—urinary bladder cancer	0.000153	0.000643	CcSEcCtD
Nicotine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000153	0.000643	CcSEcCtD
Nicotine—Convulsion—Epirubicin—urinary bladder cancer	0.000152	0.000638	CcSEcCtD
Nicotine—Nausea—Etoposide—urinary bladder cancer	0.000152	0.000637	CcSEcCtD
Nicotine—Hypertension—Epirubicin—urinary bladder cancer	0.000151	0.000636	CcSEcCtD
Nicotine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000151	0.000633	CcSEcCtD
Nicotine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00015	0.00063	CcSEcCtD
Nicotine—Arthralgia—Epirubicin—urinary bladder cancer	0.000149	0.000627	CcSEcCtD
Nicotine—Myalgia—Epirubicin—urinary bladder cancer	0.000149	0.000627	CcSEcCtD
Nicotine—Chest pain—Epirubicin—urinary bladder cancer	0.000149	0.000627	CcSEcCtD
Nicotine—Agitation—Doxorubicin—urinary bladder cancer	0.000149	0.000627	CcSEcCtD
Nicotine—Anxiety—Epirubicin—urinary bladder cancer	0.000149	0.000625	CcSEcCtD
Nicotine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000148	0.000621	CcSEcCtD
Nicotine—Discomfort—Epirubicin—urinary bladder cancer	0.000147	0.00062	CcSEcCtD
Nicotine—Malaise—Doxorubicin—urinary bladder cancer	0.000146	0.000615	CcSEcCtD
Nicotine—Dry mouth—Epirubicin—urinary bladder cancer	0.000146	0.000614	CcSEcCtD
Nicotine—Vertigo—Doxorubicin—urinary bladder cancer	0.000146	0.000613	CcSEcCtD
Nicotine—Syncope—Doxorubicin—urinary bladder cancer	0.000145	0.000611	CcSEcCtD
Nicotine—Confusional state—Epirubicin—urinary bladder cancer	0.000144	0.000606	CcSEcCtD
Nicotine—Palpitations—Doxorubicin—urinary bladder cancer	0.000143	0.000603	CcSEcCtD
Nicotine—Oedema—Epirubicin—urinary bladder cancer	0.000143	0.000601	CcSEcCtD
Nicotine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000143	0.000601	CcSEcCtD
Nicotine—Hypotension—Methotrexate—urinary bladder cancer	0.000143	0.0006	CcSEcCtD
Nicotine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000143	0.000599	CcSEcCtD
Nicotine—Cough—Doxorubicin—urinary bladder cancer	0.000142	0.000595	CcSEcCtD
Nicotine—Shock—Epirubicin—urinary bladder cancer	0.000141	0.000592	CcSEcCtD
Nicotine—Convulsion—Doxorubicin—urinary bladder cancer	0.000141	0.000591	CcSEcCtD
Nicotine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00014	0.00059	CcSEcCtD
Nicotine—Hypertension—Doxorubicin—urinary bladder cancer	0.00014	0.000589	CcSEcCtD
Nicotine—Tachycardia—Epirubicin—urinary bladder cancer	0.00014	0.000587	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000139	0.000585	CcSEcCtD
Nicotine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000138	0.000581	CcSEcCtD
Nicotine—Insomnia—Methotrexate—urinary bladder cancer	0.000138	0.000581	CcSEcCtD
Nicotine—Chest pain—Doxorubicin—urinary bladder cancer	0.000138	0.00058	CcSEcCtD
Nicotine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000138	0.00058	CcSEcCtD
Nicotine—Myalgia—Doxorubicin—urinary bladder cancer	0.000138	0.00058	CcSEcCtD
Nicotine—Anxiety—Doxorubicin—urinary bladder cancer	0.000138	0.000578	CcSEcCtD
Nicotine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000137	0.000577	CcSEcCtD
Nicotine—Discomfort—Doxorubicin—urinary bladder cancer	0.000136	0.000574	CcSEcCtD
Nicotine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000136	0.000573	CcSEcCtD
Nicotine—Somnolence—Methotrexate—urinary bladder cancer	0.000136	0.000571	CcSEcCtD
Nicotine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000135	0.000568	CcSEcCtD
Nicotine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000135	0.000566	CcSEcCtD
Nicotine—Hypotension—Epirubicin—urinary bladder cancer	0.000134	0.000562	CcSEcCtD
Nicotine—Confusional state—Doxorubicin—urinary bladder cancer	0.000133	0.000561	CcSEcCtD
Nicotine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000132	0.000556	CcSEcCtD
Nicotine—Oedema—Doxorubicin—urinary bladder cancer	0.000132	0.000556	CcSEcCtD
Nicotine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000132	0.000555	CcSEcCtD
Nicotine—Fatigue—Methotrexate—urinary bladder cancer	0.000132	0.000554	CcSEcCtD
Nicotine—Pain—Methotrexate—urinary bladder cancer	0.000131	0.00055	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00013	0.000548	CcSEcCtD
Nicotine—Shock—Doxorubicin—urinary bladder cancer	0.00013	0.000547	CcSEcCtD
Nicotine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00013	0.000546	CcSEcCtD
Nicotine—Insomnia—Epirubicin—urinary bladder cancer	0.000129	0.000544	CcSEcCtD
Nicotine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000129	0.000543	CcSEcCtD
Nicotine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000128	0.00054	CcSEcCtD
Nicotine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000128	0.000538	CcSEcCtD
Nicotine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000128	0.000536	CcSEcCtD
Nicotine—Somnolence—Epirubicin—urinary bladder cancer	0.000127	0.000535	CcSEcCtD
Nicotine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000126	0.00053	CcSEcCtD
Nicotine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000126	0.000529	CcSEcCtD
Nicotine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000125	0.000525	CcSEcCtD
Nicotine—Hypotension—Doxorubicin—urinary bladder cancer	0.000124	0.00052	CcSEcCtD
Nicotine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000124	0.000519	CcSEcCtD
Nicotine—Fatigue—Epirubicin—urinary bladder cancer	0.000123	0.000518	CcSEcCtD
Nicotine—Constipation—Epirubicin—urinary bladder cancer	0.000122	0.000514	CcSEcCtD
Nicotine—Pain—Epirubicin—urinary bladder cancer	0.000122	0.000514	CcSEcCtD
Nicotine—Urticaria—Methotrexate—urinary bladder cancer	0.000121	0.000511	CcSEcCtD
Nicotine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000121	0.000508	CcSEcCtD
Nicotine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000121	0.000508	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000121	0.000507	CcSEcCtD
Nicotine—Insomnia—Doxorubicin—urinary bladder cancer	0.00012	0.000503	CcSEcCtD
Nicotine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000119	0.0005	CcSEcCtD
Nicotine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000118	0.000496	CcSEcCtD
Nicotine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000118	0.000496	CcSEcCtD
Nicotine—Somnolence—Doxorubicin—urinary bladder cancer	0.000118	0.000495	CcSEcCtD
Nicotine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000117	0.000492	CcSEcCtD
Nicotine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000117	0.00049	CcSEcCtD
Nicotine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000114	0.00048	CcSEcCtD
Nicotine—Fatigue—Doxorubicin—urinary bladder cancer	0.000114	0.00048	CcSEcCtD
Nicotine—Urticaria—Epirubicin—urinary bladder cancer	0.000114	0.000478	CcSEcCtD
Nicotine—Pain—Doxorubicin—urinary bladder cancer	0.000113	0.000476	CcSEcCtD
Nicotine—Constipation—Doxorubicin—urinary bladder cancer	0.000113	0.000476	CcSEcCtD
Nicotine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000113	0.000475	CcSEcCtD
Nicotine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000113	0.000475	CcSEcCtD
Nicotine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000113	0.000473	CcSEcCtD
Nicotine—Asthenia—Methotrexate—urinary bladder cancer	0.00011	0.000461	CcSEcCtD
Nicotine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000109	0.000459	CcSEcCtD
Nicotine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000108	0.000455	CcSEcCtD
Nicotine—Pruritus—Methotrexate—urinary bladder cancer	0.000108	0.000455	CcSEcCtD
Nicotine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000105	0.000443	CcSEcCtD
Nicotine—Urticaria—Doxorubicin—urinary bladder cancer	0.000105	0.000442	CcSEcCtD
Nicotine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000105	0.00044	CcSEcCtD
Nicotine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000105	0.00044	CcSEcCtD
Nicotine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000105	0.00044	CcSEcCtD
Nicotine—Asthenia—Epirubicin—urinary bladder cancer	0.000103	0.000431	CcSEcCtD
Nicotine—Pruritus—Epirubicin—urinary bladder cancer	0.000101	0.000425	CcSEcCtD
Nicotine—Dizziness—Methotrexate—urinary bladder cancer	0.000101	0.000425	CcSEcCtD
Nicotine—Diarrhoea—Epirubicin—urinary bladder cancer	9.79e-05	0.000411	CcSEcCtD
Nicotine—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.75e-05	0.00041	CcSEcCtD
Nicotine—Vomiting—Methotrexate—urinary bladder cancer	9.72e-05	0.000409	CcSEcCtD
Nicotine—Rash—Methotrexate—urinary bladder cancer	9.64e-05	0.000405	CcSEcCtD
Nicotine—Dermatitis—Methotrexate—urinary bladder cancer	9.63e-05	0.000405	CcSEcCtD
Nicotine—Headache—Methotrexate—urinary bladder cancer	9.58e-05	0.000403	CcSEcCtD
Nicotine—Asthenia—Doxorubicin—urinary bladder cancer	9.5e-05	0.000399	CcSEcCtD
Nicotine—Dizziness—Epirubicin—urinary bladder cancer	9.46e-05	0.000398	CcSEcCtD
Nicotine—Pruritus—Doxorubicin—urinary bladder cancer	9.37e-05	0.000394	CcSEcCtD
Nicotine—Vomiting—Epirubicin—urinary bladder cancer	9.1e-05	0.000382	CcSEcCtD
Nicotine—Nausea—Methotrexate—urinary bladder cancer	9.08e-05	0.000382	CcSEcCtD
Nicotine—Diarrhoea—Doxorubicin—urinary bladder cancer	9.06e-05	0.000381	CcSEcCtD
Nicotine—Rash—Epirubicin—urinary bladder cancer	9.02e-05	0.000379	CcSEcCtD
Nicotine—Dermatitis—Epirubicin—urinary bladder cancer	9.01e-05	0.000379	CcSEcCtD
Nicotine—Headache—Epirubicin—urinary bladder cancer	8.96e-05	0.000377	CcSEcCtD
Nicotine—Dizziness—Doxorubicin—urinary bladder cancer	8.75e-05	0.000368	CcSEcCtD
Nicotine—Nausea—Epirubicin—urinary bladder cancer	8.5e-05	0.000357	CcSEcCtD
Nicotine—Vomiting—Doxorubicin—urinary bladder cancer	8.42e-05	0.000354	CcSEcCtD
Nicotine—Rash—Doxorubicin—urinary bladder cancer	8.35e-05	0.000351	CcSEcCtD
Nicotine—Dermatitis—Doxorubicin—urinary bladder cancer	8.34e-05	0.000351	CcSEcCtD
Nicotine—Headache—Doxorubicin—urinary bladder cancer	8.29e-05	0.000349	CcSEcCtD
Nicotine—Nausea—Doxorubicin—urinary bladder cancer	7.86e-05	0.000331	CcSEcCtD
Nicotine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	1.81e-05	9.88e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	1.79e-05	9.8e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	1.79e-05	9.8e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.79e-05	9.79e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.78e-05	9.74e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PPARG—urinary bladder cancer	1.78e-05	9.71e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.78e-05	9.71e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	1.77e-05	9.68e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.77e-05	9.67e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.76e-05	9.63e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GPX1—urinary bladder cancer	1.76e-05	9.62e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ERCC2—urinary bladder cancer	1.73e-05	9.45e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ENO2—urinary bladder cancer	1.72e-05	9.41e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	1.72e-05	9.41e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GPX1—urinary bladder cancer	1.72e-05	9.39e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.71e-05	9.35e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CREBBP—urinary bladder cancer	1.71e-05	9.33e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.71e-05	9.33e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.71e-05	9.31e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	1.69e-05	9.25e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	1.69e-05	9.21e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	1.67e-05	9.12e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTGS2—urinary bladder cancer	1.65e-05	9.03e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.65e-05	8.99e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—MTHFR—urinary bladder cancer	1.63e-05	8.88e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.62e-05	8.86e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.61e-05	8.78e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.59e-05	8.7e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	1.59e-05	8.66e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.58e-05	8.63e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.58e-05	8.63e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	1.58e-05	8.62e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—TYMS—urinary bladder cancer	1.57e-05	8.6e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.57e-05	8.57e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	1.56e-05	8.5e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	1.56e-05	8.5e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	1.55e-05	8.49e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.53e-05	8.37e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.52e-05	8.32e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.52e-05	8.31e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.52e-05	8.3e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.51e-05	8.24e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.51e-05	8.22e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.5e-05	8.21e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	1.49e-05	8.14e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.47e-05	8.04e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—TYMS—urinary bladder cancer	1.47e-05	8.01e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.47e-05	8.01e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	1.46e-05	7.99e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.46e-05	7.97e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	1.45e-05	7.92e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	1.45e-05	7.92e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—TYMS—urinary bladder cancer	1.45e-05	7.89e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTEN—urinary bladder cancer	1.44e-05	7.87e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	1.43e-05	7.8e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	1.43e-05	7.8e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.41e-05	7.7e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.41e-05	7.7e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.4e-05	7.65e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.4e-05	7.65e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTGS2—urinary bladder cancer	1.4e-05	7.64e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GPX1—urinary bladder cancer	1.39e-05	7.58e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NQO1—urinary bladder cancer	1.39e-05	7.58e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.39e-05	7.58e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	1.38e-05	7.51e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—EP300—urinary bladder cancer	1.37e-05	7.51e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.37e-05	7.5e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GPX1—urinary bladder cancer	1.37e-05	7.47e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.37e-05	7.47e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	1.36e-05	7.45e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.35e-05	7.36e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.35e-05	7.35e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	1.34e-05	7.33e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PPARG—urinary bladder cancer	1.32e-05	7.2e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.3e-05	7.08e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.3e-05	7.08e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PPARG—urinary bladder cancer	1.29e-05	7.02e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.29e-05	7.02e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.29e-05	7.02e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	1.28e-05	7e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.28e-05	6.98e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.27e-05	6.95e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CREBBP—urinary bladder cancer	1.27e-05	6.92e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.26e-05	6.89e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.26e-05	6.87e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.25e-05	6.85e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.25e-05	6.81e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	1.24e-05	6.75e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.24e-05	6.75e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.23e-05	6.71e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.23e-05	6.7e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTEN—urinary bladder cancer	1.22e-05	6.66e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.19e-05	6.48e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.17e-05	6.42e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.17e-05	6.4e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.17e-05	6.37e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—EP300—urinary bladder cancer	1.16e-05	6.35e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	1.16e-05	6.32e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.15e-05	6.29e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.15e-05	6.29e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.14e-05	6.24e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.14e-05	6.21e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.13e-05	6.16e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.13e-05	6.16e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.12e-05	6.12e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	1.12e-05	6.09e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.1e-05	6.03e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.1e-05	6.02e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.1e-05	6e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.1e-05	6e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.09e-05	5.96e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.08e-05	5.92e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.08e-05	5.9e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.08e-05	5.88e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—TYMS—urinary bladder cancer	1.08e-05	5.88e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	1.07e-05	5.85e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.07e-05	5.82e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	1.06e-05	5.81e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	1.06e-05	5.81e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.06e-05	5.8e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.06e-05	5.8e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.06e-05	5.79e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.05e-05	5.73e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.05e-05	5.71e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PPARG—urinary bladder cancer	1.04e-05	5.68e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTGS2—urinary bladder cancer	1.04e-05	5.66e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.04e-05	5.66e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.03e-05	5.61e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.02e-05	5.59e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GPX1—urinary bladder cancer	1.02e-05	5.57e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.02e-05	5.56e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	5.53e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.01e-05	5.49e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	1e-05	5.46e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	9.98e-06	5.45e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	9.98e-06	5.45e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	9.87e-06	5.39e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	9.83e-06	5.37e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	9.76e-06	5.33e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	9.76e-06	5.33e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.61e-06	5.25e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	9.48e-06	5.18e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	9.41e-06	5.14e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	9.34e-06	5.1e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	9.17e-06	5.01e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.17e-06	5.01e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	9.15e-06	5e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTEN—urinary bladder cancer	9.05e-06	4.94e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	8.85e-06	4.84e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTEN—urinary bladder cancer	8.82e-06	4.82e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	8.81e-06	4.81e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	8.77e-06	4.79e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.77e-06	4.79e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	8.72e-06	4.76e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	8.71e-06	4.76e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	8.71e-06	4.76e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	8.64e-06	4.72e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—EP300—urinary bladder cancer	8.63e-06	4.71e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	8.62e-06	4.71e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.59e-06	4.69e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8.48e-06	4.63e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8.48e-06	4.63e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—EP300—urinary bladder cancer	8.41e-06	4.6e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.36e-06	4.57e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	8.34e-06	4.55e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	8.26e-06	4.51e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	8.22e-06	4.49e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	8.19e-06	4.47e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	8.18e-06	4.47e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	8.1e-06	4.43e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	8.09e-06	4.42e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	8.05e-06	4.4e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	8.03e-06	4.39e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	8.01e-06	4.37e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	8.01e-06	4.37e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	7.94e-06	4.34e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	7.94e-06	4.34e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	7.93e-06	4.33e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	7.77e-06	4.24e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	7.7e-06	4.2e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	7.67e-06	4.19e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	7.65e-06	4.18e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PPARG—urinary bladder cancer	7.63e-06	4.17e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	7.6e-06	4.15e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	7.53e-06	4.11e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.49e-06	4.09e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	7.47e-06	4.08e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	7.38e-06	4.03e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	7.33e-06	4e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—EP300—urinary bladder cancer	7.3e-06	3.98e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.14e-06	3.9e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	7.13e-06	3.89e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	7.08e-06	3.87e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTEN—urinary bladder cancer	7.02e-06	3.84e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	7.02e-06	3.83e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	6.99e-06	3.82e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	6.86e-06	3.75e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.83e-06	3.73e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—EP300—urinary bladder cancer	6.8e-06	3.71e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	6.79e-06	3.71e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	6.79e-06	3.71e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	6.72e-06	3.67e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—EP300—urinary bladder cancer	6.7e-06	3.66e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	6.5e-06	3.55e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	6.5e-06	3.55e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	6.38e-06	3.48e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	6.36e-06	3.48e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	6.24e-06	3.41e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	6e-06	3.28e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	6e-06	3.28e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	6e-06	3.27e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	5.74e-06	3.14e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.7e-06	3.11e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	5.69e-06	3.11e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	5.67e-06	3.09e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	5.55e-06	3.03e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	5.51e-06	3.01e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	5.5e-06	3e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	5.47e-06	2.99e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—EP300—urinary bladder cancer	5.4e-06	2.95e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.3e-06	2.89e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—EP300—urinary bladder cancer	5.29e-06	2.89e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.24e-06	2.86e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.24e-06	2.86e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTEN—urinary bladder cancer	5.23e-06	2.86e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.02e-06	2.74e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—EP300—urinary bladder cancer	4.99e-06	2.73e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.92e-06	2.69e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	4.91e-06	2.68e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.86e-06	2.66e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	4.8e-06	2.62e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.67e-06	2.55e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.63e-06	2.53e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—EP300—urinary bladder cancer	4.57e-06	2.5e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.52e-06	2.47e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	4.48e-06	2.44e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	4.28e-06	2.34e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.08e-06	2.23e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.94e-06	2.15e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.9e-06	2.13e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.83e-06	2.09e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.76e-06	2.05e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.75e-06	2.05e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.72e-06	2.03e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.61e-06	1.97e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.34e-06	1.82e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.18e-06	1.74e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.95e-06	1.61e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.57e-06	1.41e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.46e-06	1.34e-05	CbGpPWpGaD
